Literature DB >> 25900369

Nucleoside diphosphate kinase B deficiency causes a diabetes-like vascular pathology via up-regulation of endothelial angiopoietin-2 in the retina.

Yi Qiu1, Di Zhao1, Vicki-Marie Butenschön1, Alexander T Bauer2, Stefan W Schneider2, Edward Y Skolnik3, Hans-Peter Hammes4, Thomas Wieland1, Yuxi Feng5.   

Abstract

AIMS: Nucleoside diphosphate kinase B (NDPKB) is capable of maintaining the cellular nucleotide triphosphate pools. It might therefore supply UTP for the formation of UDP-GlcNAc from glucose. As NDPKB contributes to vascular dysfunction, we speculate that NDPKB might play a role in microangiopathies, such as diabetic retinopathy (DR). Therefore, we investigated the impact of NDPKB on retinal vascular damage using NDPKB(-/-) mice during development of DR and its possible mechanisms.
METHODS: Pericyte loss and acellular capillary (AC) formation were assessed in streptozotocin-induced diabetic NDPKB(-/-) and wild-type (WT) mice. Expression of angiopoietin-2 (Ang2) and protein N-acetylglucosamine modification (GlcNAcylation) were assessed by western blot and/or immunofluorescence in the diabetic retinas as well as in endothelial cells depleted of NDPKB by siRNA and stimulated with high glucose.
RESULTS: Similar to diabetic WT retinas, non-diabetic NDPKB(-/-) retinas showed a significant decrease in pericyte coverage in comparison with non-diabetic WT retinas. Hyperglycemia further aggravates pericyte loss in diabetic NDPKB(-/-) retinas. AC formation was detected in the diabetic NDPKB(-/-) retinas. Similar to hyperglycemia, NDPKB deficiency induced Ang2 expression and protein GlcNAcylation that were not further altered in the diabetic retinas. In cultured endothelial cells, stimulation with high glucose and NDPKB depletion comparably increased Ang2 expression and protein GlcNAcylation.
CONCLUSIONS: Our data identify NDPKB as a protective factor in the retina, which controls Ang2 expression and the hexosamine pathway. NDPKB-deficient mice are a suitable model for studying mechanisms underlying diabetic retinal vascular damage.

Entities:  

Keywords:  Angiopoietin 2; Diabetic retinopathy; Nucleoside diphosphate kinase B; O-linked acetylglucosamine; Retina

Mesh:

Substances:

Year:  2015        PMID: 25900369     DOI: 10.1007/s00592-015-0752-x

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  11 in total

Review 1.  Regulation of heterotrimeric G-protein signaling by NDPK/NME proteins and caveolins: an update.

Authors:  Issam H Abu-Taha; Jordi Heijman; Yuxi Feng; Christiane Vettel; Dobromir Dobrev; Thomas Wieland
Journal:  Lab Invest       Date:  2017-10-16       Impact factor: 5.662

Review 2.  Therapeutic targeting of the angiopoietin-TIE pathway.

Authors:  Pipsa Saharinen; Lauri Eklund; Kari Alitalo
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

3.  Nucleoside diphosphate kinase B regulates angiogenic responses in the endothelium via caveolae formation and c-Src-mediated caveolin-1 phosphorylation.

Authors:  Shalini Gross; Kavi Devraj; Yuxi Feng; Jadranka Macas; Stefan Liebner; Thomas Wieland
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 4.  Brain and Retinal Pericytes: Origin, Function and Role.

Authors:  Andrea Trost; Simona Lange; Falk Schroedl; Daniela Bruckner; Karolina A Motloch; Barbara Bogner; Alexandra Kaser-Eichberger; Clemens Strohmaier; Christian Runge; Ludwig Aigner; Francisco J Rivera; Herbert A Reitsamer
Journal:  Front Cell Neurosci       Date:  2016-02-04       Impact factor: 5.505

5.  Single-cell transcriptomics unveils gene regulatory network plasticity.

Authors:  Giovanni Iacono; Ramon Massoni-Badosa; Holger Heyn
Journal:  Genome Biol       Date:  2019-06-04       Impact factor: 13.583

Review 6.  Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential.

Authors:  Michael Whitehead; Andrew Osborne; Peter S Widdowson; Patrick Yu-Wai-Man; Keith R Martin
Journal:  J Diabetes Res       Date:  2019-08-14       Impact factor: 4.011

7.  O-GlcNAcylation of FoxO1 mediates nucleoside diphosphate kinase B deficiency induced endothelial damage.

Authors:  Shenliang Shan; Anupriya Chatterjee; Yi Qiu; Hans-Peter Hammes; Thomas Wieland; Yuxi Feng
Journal:  Sci Rep       Date:  2018-07-12       Impact factor: 4.379

8.  Role of the Ang2-Tie2 Axis in Vascular Damage Driven by High Glucose or Nucleoside Diphosphate Kinase B Deficiency.

Authors:  Anupriya Chatterjee; Rachana Eshwaran; Hongpeng Huang; Di Zhao; Martina Schmidt; Thomas Wieland; Yuxi Feng
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

9.  Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity.

Authors:  Anupriya Chatterjee; Rachana Eshwaran; Gernot Poschet; Santosh Lomada; Mahmoud Halawa; Kerstin Wilhelm; Martina Schmidt; Hans-Peter Hammes; Thomas Wieland; Yuxi Feng
Journal:  Cells       Date:  2020-10-19       Impact factor: 6.600

10.  Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model.

Authors:  Ailing Sui; Xiuping Chen; Jikui Shen; Anna M Demetriades; Yiyun Yao; Yixuan Yao; Yanji Zhu; Xi Shen; Bing Xie
Journal:  Cell Death Dis       Date:  2020-10-22       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.